TPST

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Tempest Therapeutics Inc

NASDAQ | TPST

9.58

USD

$0.00

(

0.00%

)

At Close (As of Sep 17, 2025)

$44.71M

Market Cap

-

P/E Ratio

-14.52

EPS

$20.67

52 Week High

$5.35

52 Week Low

HEALTHCARE

Sector

TPST Chart

Recent Chart
Price Action

TPST Technicals

Tags:

TPST Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$389K
Total Revenue $0
Cost Of Revenue $389K
Costof Goods And Services Sold $389K
Operating Income -$42M
Selling General And Administrative $14M
Research And Development $28M
Operating Expenses $42M
Investment Income Net -
Net Interest Income $183K
Interest Income $1.5M
Interest Expense $1.3M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $389K
Income Before Tax -$42M
Income Tax Expense -$42M
Interest And Debt Expense -
Net Income From Continuing Operations -$42M
Comprehensive Income Net Of Tax -
Ebit -$41M
Ebitda -$40M
Net Income -$42M

Revenue & Profitability

Earnings Performance

TPST Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $41M
Total Current Assets $31M
Cash And Cash Equivalents At Carrying Value $30M
Cash And Short Term Investments $30M
Inventory -
Current Net Receivables -
Total Non Current Assets $10M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $1.2M
Other Non Current Assets -
Total Liabilities $22M
Total Current Liabilities $14M
Current Accounts Payable $2.5M
Deferred Revenue -
Current Debt -
Short Term Debt $7.2M
Total Non Current Liabilities $8.1M
Capital Lease Obligations $9M
Long Term Debt -
Current Long Term Debt $6.4M
Long Term Debt Noncurrent -
Short Long Term Debt Total $15M
Other Current Liabilities $4.5M
Other Non Current Liabilities -
Total Shareholder Equity $19M
Treasury Stock -
Retained Earnings -$207M
Common Stock $44K
Common Stock Shares Outstanding $28M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$33M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $389K
Capital Expenditures $435K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$435K
Cashflow From Financing $25M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$42M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$389K
Total Revenue $0
Cost Of Revenue $389K
Costof Goods And Services Sold $389K
Operating Income -$42M
Selling General And Administrative $14M
Research And Development $28M
Operating Expenses $42M
Investment Income Net -
Net Interest Income $183K
Interest Income $1.5M
Interest Expense $1.3M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $389K
Income Before Tax -$42M
Income Tax Expense -$42M
Interest And Debt Expense -
Net Income From Continuing Operations -$42M
Comprehensive Income Net Of Tax -
Ebit -$41M
Ebitda -$40M
Net Income -$42M

TPST News

TPST Profile

Tempest Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Tempest Therapeutics Inc. (TPST) is an innovative clinical-stage oncology company based in South San Francisco, California, focusing on the development of proprietary small molecules designed to harness both targeted therapies and immune-mediated mechanisms for the treatment of diverse tumors. With a commitment to advancing cancer therapeutics, Tempest's pipeline includes compounds that aim to improve patient outcomes in challenging oncology indications, positioning the company at the forefront of cancer research and development. As the landscape of oncology continues to evolve, Tempest seeks to leverage its unique approach to provide new treatment options for patients, thereby enhancing value for shareholders and contributing to the broader fight against cancer.

ATCH
+84.47%
$1.59
NVDA
-2.62%
$170.29
PLUG
+19.04%
$2.00
CGBS
-39.47%
$0.03
CDT
+40.10%
$0.89
BITF
+5.53%
$3.05
SNAP
+3.16%
$7.98
NFE
+8.00%
$2.16
SPRC
+142.93%
$4.47
NIO
+6.05%
$7.44
QBTS
+19.44%
$22.66
GRAB
-3.48%
$6.10
TSLA
+1.00%
$425.86
AAL
+0.84%
$12.51
LYFT
+13.12%
$22.84
GV
+68.16%
$2.80
NUAI
-4.00%
$0.45
MARA
-1.08%
$17.34
SOUN
+3.25%
$15.16
KDLY
+20.96%
$1.50
SOFI
-1.02%
$27.14
RGTI
+9.92%
$21.98
TPIC
-45.91%
$0.12
PLTR
-1.13%
$168.33
DNN
+1.40%
$2.53
AXDX
-61.36%
$0.03
ADAP
-1.22%
$0.08
BBD
+2.95%
$3.30
PGRE
-11.43%
$6.54
F
+0.52%
$11.67
INTC
-1.46%
$24.90
BMNR
+1.98%
$57.04
TNMG
-0.27%
$0.32
IPM
+29.01%
$2.49
LYT
-16.77%
$0.09
JOBY
-1.59%
$14.16
BTG
+0.46%
$4.34
MULN
-12.58%
$0.06
WBD
-1.42%
$17.98
RR
+2.84%
$3.98
NAKA
-4.66%
$1.43
RIVN
-1.46%
$14.11
AAPL
+0.35%
$238.99
UBER
-4.95%
$92.98
ACHR
-1.20%
$9.00
ONDS
+0.16%
$6.10
QS
+1.08%
$10.26
IONQ
+4.97%
$65.36
ABEV
0.00%
$2.36
AIRE
-1.57%
$1.25
LDI
+2.70%
$4.55
PFE
+0.56%
$24.03
RIOT
+0.82%
$17.66
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
WULF
+3.93%
$11.37
OPI
-31.80%
$0.56
RELI
+6.58%
$0.72
TLRY
-2.45%
$1.19
AMD
-0.60%
$159.49
ETHD
-1.52%
$3.22
SRM
+53.27%
$10.30
VALE
-0.27%
$10.88
BINI
-10.60%
$0.05
NOK
+1.84%
$4.69
GOOGL
-0.64%
$249.53
CIFR
+7.55%
$12.38
IREN
+3.97%
$37.90
NWTN
+12.58%
$1.70
CWD
+19.05%
$7.56
AMZN
-1.40%
$230.76
JD
+1.52%
$35.24
ATYR
-5.09%
$1.02
QUBT
+5.21%
$17.75
ITUB
+1.82%
$7.27
INFY
+3.60%
$17.67
RZLV
-3.60%
$7.08
RIG
-1.87%
$3.40
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
KEY
+0.42%
$18.71
DVLT
-21.32%
$0.35
FAAS
-8.85%
$0.08
BABA
+2.39%
$166.09
HOOD
+1.23%
$118.82
BAC
+1.41%
$51.37
BTE
-2.49%
$2.54
WLGS
-5.57%
$0.04
T
-0.97%
$29.33
HBAN
+0.63%
$17.54
CLSK
+2.14%
$11.44
JBLU
0.00%
$5.07
BURU
-0.93%
$0.13
HIMS
-1.08%
$50.34
ETWO
0.00%
$3.30
CAN
+0.23%
$0.80
PEB
+2.03%
$11.79
RAYA
-3.83%
$0.04
GDXD
+2.45%
$1.25
IONZ
-10.28%
$4.80
ATCH
+84.47%
$1.59
NVDA
-2.62%
$170.29
PLUG
+19.04%
$2.00
CGBS
-39.47%
$0.03
CDT
+40.10%
$0.89
BITF
+5.53%
$3.05
SNAP
+3.16%
$7.98
NFE
+8.00%
$2.16
SPRC
+142.93%
$4.47
NIO
+6.05%
$7.44
QBTS
+19.44%
$22.66
GRAB
-3.48%
$6.10
TSLA
+1.00%
$425.86
AAL
+0.84%
$12.51
LYFT
+13.12%
$22.84
GV
+68.16%
$2.80
NUAI
-4.00%
$0.45
MARA
-1.08%
$17.34
SOUN
+3.25%
$15.16
KDLY
+20.96%
$1.50
SOFI
-1.02%
$27.14
RGTI
+9.92%
$21.98
TPIC
-45.91%
$0.12
PLTR
-1.13%
$168.33
DNN
+1.40%
$2.53
AXDX
-61.36%
$0.03
ADAP
-1.22%
$0.08
BBD
+2.95%
$3.30
PGRE
-11.43%
$6.54
F
+0.52%
$11.67
INTC
-1.46%
$24.90
BMNR
+1.98%
$57.04
TNMG
-0.27%
$0.32
IPM
+29.01%
$2.49
LYT
-16.77%
$0.09
JOBY
-1.59%
$14.16
BTG
+0.46%
$4.34
MULN
-12.58%
$0.06
WBD
-1.42%
$17.98
RR
+2.84%
$3.98
NAKA
-4.66%
$1.43
RIVN
-1.46%
$14.11
AAPL
+0.35%
$238.99
UBER
-4.95%
$92.98
ACHR
-1.20%
$9.00
ONDS
+0.16%
$6.10
QS
+1.08%
$10.26
IONQ
+4.97%
$65.36
ABEV
0.00%
$2.36
AIRE
-1.57%
$1.25
LDI
+2.70%
$4.55
PFE
+0.56%
$24.03
RIOT
+0.82%
$17.66
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
WULF
+3.93%
$11.37
OPI
-31.80%
$0.56
RELI
+6.58%
$0.72
TLRY
-2.45%
$1.19
AMD
-0.60%
$159.49
ETHD
-1.52%
$3.22
SRM
+53.27%
$10.30
VALE
-0.27%
$10.88
BINI
-10.60%
$0.05
NOK
+1.84%
$4.69
GOOGL
-0.64%
$249.53
CIFR
+7.55%
$12.38
IREN
+3.97%
$37.90
NWTN
+12.58%
$1.70
CWD
+19.05%
$7.56
AMZN
-1.40%
$230.76
JD
+1.52%
$35.24
ATYR
-5.09%
$1.02
QUBT
+5.21%
$17.75
ITUB
+1.82%
$7.27
INFY
+3.60%
$17.67
RZLV
-3.60%
$7.08
RIG
-1.87%
$3.40
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
KEY
+0.42%
$18.71
DVLT
-21.32%
$0.35
FAAS
-8.85%
$0.08
BABA
+2.39%
$166.09
HOOD
+1.23%
$118.82
BAC
+1.41%
$51.37
BTE
-2.49%
$2.54
WLGS
-5.57%
$0.04
T
-0.97%
$29.33
HBAN
+0.63%
$17.54
CLSK
+2.14%
$11.44
JBLU
0.00%
$5.07
BURU
-0.93%
$0.13
HIMS
-1.08%
$50.34
ETWO
0.00%
$3.30
CAN
+0.23%
$0.80
PEB
+2.03%
$11.79
RAYA
-3.83%
$0.04
GDXD
+2.45%
$1.25
IONZ
-10.28%
$4.80
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.